FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912884963> ?p ?o ?g. }

• W2912884963 endingPage "1324" @default.
• W2912884963 startingPage "1313" @default.
• W2912884963 abstract "The immunomodulatory effects of statins on vaccine response remain uncertain. Therefore, the objective of this study was to determine if atorvastatin enhances pneumococcal-specific antibody titer following 23-valent pneumococcal polysaccharide vaccination. Double-blind, placebo-controlled, single-center randomized clinical trial entitled StatVax. Subjects were enrolled between June and July 2014 and followed up through September 2014. 33 healthy volunteers signed informed consent after volunteer sampling. 11 participants were excluded; 22 healthy volunteers without prior pneumococcal vaccination were enrolled and completed the study. Participants were randomized to receive a 28-day course of 40 mg atorvastatin (n = 12) or matching lactose placebo (n = 10). On day 7 of treatment, Pneumovax 23 was administered intramuscularly. The primary outcome was fold change in total pneumococcal-specific antibody titer determined by a ratio of post-vaccination titer over baseline titer. Secondary outcomes included serotype-specific pneumococcal antibody titer, seroconversion, complete blood counts (CBC), erythrocyte sedimentation rate (ESR), and serum cytokine analysis. Of the 22 randomized patients (mean age, 23.86; SD, 4.121; 11 women [50%]), 22 completed the trial. Total anti-pneumococcal antibody titer in the atorvastatin group went from a baseline mean of 32.58 (SD, 15.96) to 147.7 (SD, 71.52) μg/mL at 21 days post-vaccination while titer in the placebo group went from a mean of 30.81 (SD, 13.04) to 104.4 (SD, 45) μg/mL. When comparing fold change between treatment groups, there was a significant increase in fold change of total anti-pneumococcal antibody titer in the atorvastatin group compared to the placebo group (2-way ANOVA, p = .0177). Atorvastatin enhances antigen-specific primary humoral immune response to a T cell-independent pneumonia vaccination. Pending confirmation by larger cohort studies of target populations, peri-vaccination conventional doses of statins can become a novel adjuvant for poorly-immunogenic polysaccharide-based vaccines. Trial Registration: clinicaltrials.gov Identifier: NCT02097589" @default.
• W2912884963 created "2019-02-21" @default.
• W2912884963 creator A5032105280 @default.
• W2912884963 creator A5034239729 @default.
• W2912884963 creator A5048831252 @default.
• W2912884963 creator A5057923691 @default.
• W2912884963 creator A5069306623 @default.
• W2912884963 date "2019-02-01" @default.
• W2912884963 modified "2023-10-14" @default.
• W2912884963 title "Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial" @default.
• W2912884963 cites W1507950132 @default.
• W2912884963 cites W1525331105 @default.
• W2912884963 cites W1939007604 @default.
• W2912884963 cites W1964021758 @default.
• W2912884963 cites W1965091954 @default.
• W2912884963 cites W1972004366 @default.
• W2912884963 cites W1975737364 @default.
• W2912884963 cites W1975939166 @default.
• W2912884963 cites W1980857453 @default.
• W2912884963 cites W1983592112 @default.
• W2912884963 cites W1996363381 @default.
• W2912884963 cites W2037389412 @default.
• W2912884963 cites W2044686773 @default.
• W2912884963 cites W2067236087 @default.
• W2912884963 cites W2067659597 @default.
• W2912884963 cites W2070396041 @default.
• W2912884963 cites W2097129414 @default.
• W2912884963 cites W2099065288 @default.
• W2912884963 cites W2100839274 @default.
• W2912884963 cites W2104585349 @default.
• W2912884963 cites W2113485385 @default.
• W2912884963 cites W2119964825 @default.
• W2912884963 cites W2121369371 @default.
• W2912884963 cites W2124826485 @default.
• W2912884963 cites W2128043538 @default.
• W2912884963 cites W2137140783 @default.
• W2912884963 cites W2139525991 @default.
• W2912884963 cites W2144170194 @default.
• W2912884963 cites W2154671344 @default.
• W2912884963 cites W2156506016 @default.
• W2912884963 cites W2162905114 @default.
• W2912884963 cites W2166930051 @default.
• W2912884963 cites W2167873118 @default.
• W2912884963 cites W2171064899 @default.
• W2912884963 cites W2260572233 @default.
• W2912884963 cites W2514514030 @default.
• W2912884963 cites W2552951299 @default.
• W2912884963 cites W2586073626 @default.
• W2912884963 cites W2594055403 @default.
• W2912884963 cites W4313381913 @default.
• W2912884963 cites W4313385228 @default.
• W2912884963 doi "https://doi.org/10.1016/j.vaccine.2019.01.023" @default.
• W2912884963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6379110" @default.
• W2912884963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30686636" @default.
• W2912884963 hasPublicationYear "2019" @default.
• W2912884963 type Work @default.
• W2912884963 sameAs 2912884963 @default.
• W2912884963 citedByCount "4" @default.
• W2912884963 countsByYear W29128849632020 @default.
• W2912884963 countsByYear W29128849632021 @default.
• W2912884963 crossrefType "journal-article" @default.
• W2912884963 hasAuthorship W2912884963A5032105280 @default.
• W2912884963 hasAuthorship W2912884963A5034239729 @default.
• W2912884963 hasAuthorship W2912884963A5048831252 @default.
• W2912884963 hasAuthorship W2912884963A5057923691 @default.
• W2912884963 hasAuthorship W2912884963A5069306623 @default.
• W2912884963 hasBestOaLocation W29128849631 @default.
• W2912884963 hasConcept C126322002 @default.
• W2912884963 hasConcept C142724271 @default.
• W2912884963 hasConcept C159654299 @default.
• W2912884963 hasConcept C168563851 @default.
• W2912884963 hasConcept C203014093 @default.
• W2912884963 hasConcept C204787440 @default.
• W2912884963 hasConcept C22070199 @default.
• W2912884963 hasConcept C22889606 @default.
• W2912884963 hasConcept C27081682 @default.
• W2912884963 hasConcept C2776152631 @default.
• W2912884963 hasConcept C2776768635 @default.
• W2912884963 hasConcept C2777451964 @default.
• W2912884963 hasConcept C2777482532 @default.
• W2912884963 hasConcept C2778143017 @default.
• W2912884963 hasConcept C2779301066 @default.
• W2912884963 hasConcept C2779664119 @default.
• W2912884963 hasConcept C2781253189 @default.
• W2912884963 hasConcept C3020803494 @default.
• W2912884963 hasConcept C32611913 @default.
• W2912884963 hasConcept C501593827 @default.
• W2912884963 hasConcept C6557445 @default.
• W2912884963 hasConcept C71924100 @default.
• W2912884963 hasConcept C86803240 @default.
• W2912884963 hasConcept C89423630 @default.
• W2912884963 hasConcept C90924648 @default.
• W2912884963 hasConceptScore W2912884963C126322002 @default.
• W2912884963 hasConceptScore W2912884963C142724271 @default.
• W2912884963 hasConceptScore W2912884963C159654299 @default.
• W2912884963 hasConceptScore W2912884963C168563851 @default.
• W2912884963 hasConceptScore W2912884963C203014093 @default.
• W2912884963 hasConceptScore W2912884963C204787440 @default.

• next